Lenacapavir: First Approval (vol 82, pg 1499, 2022)

被引：0

作者：

Paik, Julia ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-023-01908-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1061 / 1061

页数：1

共 50 条

[1] Spesolimab: First Approval (vol 82, pg 1681, 2022)
Blair, Hannah A.
DRUGS, 2023, 83 (01) : 103 - 103
[2] Efgartigimod: First Approval (vol 82, pg 341, 2022)
Heo, Young-A
DRUGS, 2022, 82 (05) : 611 - 611
[3] Daridorexant: First Approval (vol 82, pg 601, 2022)
Markham, Anthony
DRUGS, 2022, 82 (07) : 841 - 841
[4] Mavacamten: First Approval (vol 82, pg 1127, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (11) : 1235 - 1235
[5] Valemetostat Tosilate: First Approval (vol 82, pg 1621, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (17) : 1689 - 1689
[6] Tapinarof Cream 1%: First Approval (vol 82, pg 1221, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (13) : 1433 - 1433
[7] Nirmatrelvir Plus Ritonavir: First Approval (vol 82, pg 585, 2022)
Lamb, Yvette N.
DRUGS, 2022, 82 (09) : 1025 - 1025
[8] Tapinarof Cream 1%: First Approval (vol 82, pg 1221, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (12) : 1345 - 1345
[9] Lenacapavir: First Approval
Paik, Julia
DRUGS, 2022, 82 (14) : 1499 - 1504
[10] Lenacapavir: First Approval
Julia Paik
Drugs, 2022, 82 : 1499 - 1504